Max Healthcare Q2 Results: Net profit zooms 26% YoY to Rs 338 crore

Max Healthcare on Monday reported 26% YoY jump in net profit to Rs 338 crore in Q2FY24, on a like-to-like basis, mainly driven by improvement in operational metric like average revenue per occupied bed (ARPOB), better specialty mix and augmentation of bed capacity at Max Shalimar Bagh.

The company reported a net profit of Rs 267 crore in Q2FY23.

Gross revenue rose 17% to Rs 1827 crore during Q2FY24 compared to Rs 1,567 crore the previous year.


The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 21% YoY to Rs 497 crore. The EBITDA margin improved 100 basis points YoY to 28.7%.

All hospitals improved their ARPOB during the period and the overall average growth in ARPOB stood at over 13% YoY to Rs 74.600.
The bed occupancy in Q2FY24 stood at 77%.

In Q2FY24, the share of international patient revenues grew 25% YoY and stood at 9%.

“Q2 results are in line with our expectations and reflect the continuous focus on execution at grass root level," said Abhay Soi, chairman and managing director, Max Healthcare.

"We are well-poised to absorb addition to network bed capacity in the coming years, while we evaluate M&A targets for inorganic growth," Soi added.

“I am happy that despite the traditionally weak Q1, we could deliver our highest ever quarterly revenue and improve profitability at bed level," said Abhay Soi, chairman and managing director, Max Healthcare.

"In the past year, we have significantly strengthened our projects and digital teams to reinforce our thrust in both these areas, which is intrinsic to our growth going forward," Soi added.